Creekmur Asset Management LLC Increases Holdings in GE HealthCare Technologies Inc. $GEHC

Creekmur Asset Management LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 41.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,075 shares of the company’s stock after buying an additional 2,957 shares during the period. Creekmur Asset Management LLC’s holdings in GE HealthCare Technologies were worth $746,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Lineweaver Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth about $592,000. Exome Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth about $2,050,000. Bridge Creek Capital Management LLC increased its position in shares of GE HealthCare Technologies by 58.2% during the second quarter. Bridge Creek Capital Management LLC now owns 31,852 shares of the company’s stock worth $2,359,000 after purchasing an additional 11,719 shares in the last quarter. Czech National Bank increased its position in shares of GE HealthCare Technologies by 6.6% during the second quarter. Czech National Bank now owns 111,923 shares of the company’s stock worth $8,290,000 after purchasing an additional 6,889 shares in the last quarter. Finally, Swedbank AB increased its position in shares of GE HealthCare Technologies by 71.9% during the second quarter. Swedbank AB now owns 128,101 shares of the company’s stock worth $9,488,000 after purchasing an additional 53,575 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on GEHC shares. Evercore ISI lifted their target price on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their target price for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research report on Wednesday. Finally, Barclays started coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $86.10.

View Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $75.00 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.93. The stock has a fifty day moving average price of $75.10 and a 200 day moving average price of $72.91. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a market cap of $34.24 billion, a PE ratio of 15.50, a P/E/G ratio of 2.95 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same period last year, the company earned $1.14 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.